City

Houston (1)

Portland (1)

Saint Petersburg (1)

Overall Status

Recruiting (2)

Suspended (1)

Phase

phase 2 (2)

n/a (1)

Sponsor

M.D. Anderson Cancer Center (1)

Providence Health & Services (1)

Saint Petersburg State University, Russia (1)

Collaborator

Intervention

binimetinib (1)

chemotherapy (1)

cryosurgery (1)

encorafenib (1)

lenvatinib (1)

nivolumab (1)

pembrolizumab (1)

quality-of-life assessment (1)

stereotactic body radiation therapy (1)

Study Documents

Intervention Type

biological (2)

drug (2)

other (1)

procedure (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

metastatic thyroid gland carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting

BRAF NP_004324.2:p.V600M
+6 more

Binimetinib
+2 more

Portland, Oregon

Providence Portland Medical Center

Aug 17, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Bone Trial in

Recruiting

Castration-Resistant Prostate Carcinoma
+17 more

Cryosurgery
+2 more

Houston, Texas

M D Anderson Cancer Center

Dec 29, 2021

Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8

Suspended

Metastatic Thyroid Gland Carcinoma
+2 more

Lenvatinib
+2 more

Saint Petersburg, Russian Federation

Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H

May 13, 2021